COMMUNIQUÉS West-GlobeNewswire

Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer

18/12/2024 - 14:00

Preliminary clinical data in post-anti-PD-1 NSCLC patients demonstrated a 27% ORR and 73% DCR in monotherapy trial Monotherapy activity with inhaled KB707 provides further evidence of successful repeat administration of [...]

Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome

18/12/2024 - 14:00

Dravet syndrome is a genetic developmental and epileptic encephalopathy (DEE) often caused by a mutation in SCN1A This is the third Rare Pediatric Disease Designation for relutrigine, adding to those granted for SCN2A [...]

Septerna to Present at the 43rd Annual J.P. Morgan Healthcare Conference

18/12/2024 - 14:00

SOUTH SAN FRANCISCO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Septerna , a clinical-stage biotechnology company pioneering a new era of GPCR-targeted drug discovery, today announced that Jeffrey Finer, M.D., Ph.D., [...]

ALX Oncology to Present Updated Results from Phase 2 ASPEN-06 Clinical Trial of Evorpacept in Patients with HER2-Positive Gastric Cancer in Oral Presentation at 2025 ASCO Gastrointestinal Cancers Symposium

18/12/2024 - 14:00

SOUTH SAN FRANCISCO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the [...]

Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies

18/12/2024 - 14:18

Clinical Data from First Subject Dosed Twice Daily with QRX003 in Open Label Study Is Positive at Mid-point of Testing Significant Improvement in Skin Appearance Observed in Pediatric Study after Only 12 Days of Dosing [...]

Vandria announces first subjects dosed in its first-in-human Phase 1 clinical trial of VNA-318 brain-penetrant mitophagy inducer

18/12/2024 - 09:00

LAUSANNE, Switzerland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Vandria SA, a company at the vanguard of mitochondrial therapeutics developing first-in-class small molecule mitophagy inducers, today announces that the first [...]

Brains Bioceutical élargit son offre de cannabinoïdes leaders sur le marché avec le D9-THC et le CBN, et ouvre ainsi de nouvelles possibilités en matière de développement de médicaments

18/12/2024 - 09:07

VANCOUVER, Colombie-Britannique, 18 déc. 2024 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. (Brains Bio), leader mondial dans la fabrication d’ingrédients pharmaceutiques actifs (IPA) à base de cannabinoïdes naturels et [...]

ENA Respiratory Announces Peer-Reviewed Publication of First Time in Humans and Influenza Virus Challenge Studies with the Intranasal Innate Immunomodulator INNA-051

18/12/2024 - 10:00

When compared to placebo, prophylactic administration of INNA-051 was associated with significantly increased expression of multiple host defense genes and shorter duration of infection in influenza virus-infected [...]

Bioplastics: Paving the Way to Meet EU Packaging and Packaging Waste Regulation Goals

18/12/2024 - 11:12

BRUSSELS, Dec. 18, 2024 (GLOBE NEWSWIRE) -- European Bioplastics (EUBP) welcomes the adoption of the European Union’s ambitious Packaging and Packaging Waste Regulation (PPWR). The adoption by the Council on 16 December [...]

Roche transforms mass spectrometry diagnostics with launch of cobas® Mass Spec solution

18/12/2024 - 07:00

Roche launches its cobas ® Mass Spec solution, bringing mass spectrometry to the routine clinical lab Clinical mass spectrometry testing offers unparalleled sensitivity and specificity, providing clinicians with [...]

NMD Pharma publishes new data on the role of ClC-1 inhibition in Charcot-Marie-Tooth in the Annals of Clinical and Translational Neurology

18/12/2024 - 07:00

NMD Pharma publishes new data on the role of ClC-1 inhibition in Charcot-Marie-Tooth in the Annals of Clinical and Translational Neurology Results from the ESTABLISH 1 observational study confirms that neuromuscular [...]

ULTI – EX. RIGHT TO PARTICIPATE IN POTENTIAL REPAIR OFFERING TODAY

18/12/2024 - 08:00

Issuer name: Ultimovacs ASA Ex. date: 18 December 2024 Type of corporate action: Potential repair offering Other information: Any repair offering is subject to the prior publication of a prospectus in accordance with [...]

Dr. Todd Cevene Debuts Redesigned Website, Expanding Digital Presence in Weight Loss Industry

18/12/2024 - 03:20

Dr. Todd Cevene enhances digital accessibility with a dynamic new website, expanding resources for effective weight loss Rockford, IL , Dec. 17, 2024 (GLOBE NEWSWIRE) -- Nationally recognized weight loss specialist Dr. [...]

Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations

18/12/2024 - 03:55

VANCOUVER, British Columbia, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“ Rakovina ” or the “ Company ”) ( TSX-V: RKV ) announces that in accordance with the terms of an indenture entered into between [...]

AIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

17/12/2024 - 22:45

A Plan for Compliance has been Undertaken OCALA, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), announced today that it received a notice (the “Notice”) from [...]

Tevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference

17/12/2024 - 19:32

WARREN, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T [...]

Key information relating to the potential subsequent repair offering to be carried out by Ultimovacs ASA

17/12/2024 - 19:39

Reference is made to the stock exchange announcement by Ultimovacs ASA ("Ultimovacs" or the "Company") on 17 December 2024 regarding the agreement to combine its business with Zelluna Immunotherapy AS ("Zelluna"), the [...]

HEALWELL AI Announces Upsize in Bought Deal Offering to $55 Million

17/12/2024 - 19:40

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“ HEALWELL ” or the “ Company ”) (TSX: AIDX) (OTCQX:HWAIF), a data [...]

Laguna Treatment Center Launches Tribal Recovery Track, Expanding Culturally Competent Care for Native Americans

17/12/2024 - 21:30

ALISO VIEJO, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- With more than 100 federally recognized Native American tribes in California alone, Laguna Treatment Center is adding a new treatment track to meet the unique needs [...]